Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations
Open Access
- 23 June 2026
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 33 (6) , e70669
Abstract
Background and Purpose: Familial cerebral cavernous malformations (fCCM) may cause focal neurological deficits (FND) due to hemorrhagic or non‐hemorrhagic events and epileptic seizures (ES). With the widespread use of magnetic resonance imaging (MRI) and genetic testing, diagnosis is now frequently established at a presymptomatic stage, before any clinical manifestation. However, the subsequent risk of a first clinical event in these individuals remains poorly defined. Methods: We conducted a cohort‐based analysis of retrospectively collected longitudinal data from 79 patients with fCCM who were asymptomatic at diagnosis (median age, 41.7 years) and managed in a national referral center. Results: Over 649.6 patient‐years (median follow‐up, 4.0 years), 23 patients (29%) experienced a first clinical event. Post‐diagnostic event‐free survival was approximately 97% at 1 year, 79% at 5 years, and 69% at 10 years. Incidence rates for a first event were 35.4 per 1000 person‐years for any first event (FND or ES), 23.1 per 1000 person‐years for a first FND, and 15.4 per 1000 person‐years for a first ES. Male sex was independently associated with higher risk (HR 4.20; 95% CI, 1.60–11.04; p = 0.0036). Conclusions: These data provide pragmatic post‐diagnostic risk estimates to guide counseling and surveillance in asymptomatic fCCM.Keywords
This publication has 7 references indexed in Scilit:
- Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous MalformationsNeurology, 2025
- Clinical features, hemorrhage risk and epilepsy outcomes of familial cerebral cavernous malformation: A 20-year observational pragmatic single-center studyJournal of Stroke and Cerebrovascular Diseases, 2024
- Clinical presentation, hemorrhage risk, and outcome in patients with familial cavernous malformations: a pragmatic prospective analysis of 75 patientsJournal of Neurosurgery, 2023
- Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non‐familial diseaseEuropean Journal of Neurology, 2022
- Familial Cerebral Cavernous MalformationsStroke, 2019
- Genetics of cavernous angiomasThe Lancet Neurology, 2007
- Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformationsNeurology, 2001